Our Portfolio 

Our portfolio reflects the scale and diversity of the broader healthcare venture capital market.

 

For over 13 years, we have created customized solutions for venture funds, corporate venture funds, limited partnership interests, operating companies, and individual shareholders.

ttam_trademark_logo.74f1346e4558.png

23andMe was founded in 2006 to help people access, understand and benefit from the human genome. 

Prolacta logo_full-color.png

As a pioneer in human milk-based nutritional products, Prolacta produces specialty nutritional formulations made exclusively from human milk for critically ill premature infants in the NICU.

logo1.png

NewBridge focuses on in-licensing and commercializing approved innovative pharmaceutics, biologics, and other healthcare solutions into the Middle East and Africa regions.

CalciMedica.png

Leading CRAC channel platform company delivering drug candidates for inflammatory diseases.

logo.png

TheraVida is dedicated to the development of new therapies to improve the lives of patients with hyperhidrosis.

From mineral sunscreen to clinical skincare products, Colorescience utilizes potent, clinically-tested ingredients to maximize results for long-term skin health.

Revelation Partners_Logo-01.png

255 California Street

12th Floor

San Francisco, CA 94111

Tel: 415-905-7226

  • LinkedIn

© 2020 by Revelation Partners